I have a piece with Rahul Das and Rashmi Birmole on the new advertisement norms which are applicable to investment advisors and research analysts in the Financial Express of the 3rd May 2023. The full piece is as below:
The relationship between an investor and an investment
adviser is characterised by high levels of trust and confidence. The position
of trust and dominance occupied by investment advisers intrinsically carries
the risk of misuse, no matter how remote. Tackling this risk, and any competing
interests that may arise out of an investment adviser’s pecuniary
considerations, has historically been the focus of regulations governing the
activities of such advisers, across the world.
In India, investment advisers (IA) are governed by the
Securities and Exchange Board of India (Investment Advisers) Regulations, 2013
(IA Regulations), which prescribe a set of fiduciary duties and general
obligations in connection with an IA’s dealings with investors. In terms of
marketing activities, as per an advisory released by the Telecom Regulatory
Authority of India (TRAI) in the context of unsolicited bulk SMSs in 2017,
service providers were directed to ensure that messages from SEBI registered
IAs are only sent as transactional messages, and not in the form of promotional
messages. However, apart from the same, the marketing and advertising
activities of IAs, until recently, have largely remained unaddressed in the
absence of any clear regulatory guidelines to that effect.
On April 5, SEBI released the Advertisement Code to
regulate advertisements issued by IAs and Research Analysts (the Code). Shortly
after, SEBI also released guidelines governing the use of brand/trade names by
an IA or a Research Analyst (RA) on April 6 (Brand Use Guidelines). The Code
and the Brand Use Guidelines are scheduled to come into effect from 1st
May, and appear to have been adopted to protect inexperienced investors from
being misled by deceptive marketing tactics adopted by certain existing SEBI
registered IAs and unauthorised entities masquerading as IAs.
The Code and the Brand Use Guidelines seek to
primarily regulate the approval process and the contents of advertisements
issued by IAs/RAs. The key terms of the same have been briefly summarised
below.
Any communication issued by an IA/RA, that may
influence the investment decision of an investor, and is published or designed
for use in any publication or display, in any format, shall be considered as an
‘advertisement’. The Code shall also extend to advertisements issued by any
other investment/research/consultancy agency associated with an IA/RA, which
refers to the concerned IA/RA. IAs must obtain prior approval from the BSE
Administration & Supervision Ltd. (BASL), the designated supervisory body
for IAs, before publishing, circulating or displaying any advertisements.
Advertisements should be presented using unambiguous
and concise language and contain accurate, true and complete information. The
Code prescribes information that must be mandatorily included in an
advertisement, such as the name, registered office address, SEBI registration number,
brand name, corporate identification number, etc. In terms of the Brand Use
Guidelines, IAs/RAs should also ensure that additional details such as logo and
contact information are prominently displayed on any portal, notice board,
advertisements, publications, KYC forms and client agreements.
Advertisements shall also mandatorily contain standard
warnings against market risks, assured returns/guaranteed performance and in
case of references to specific securities, a disclaimer indicating the
illustrative nature of such references.
Further, the
Code sets forth several general prohibitions in respect of the contents of an
advertisement, which generally prohibit the use of statements or testimonials
which are or may be construed as false, misleading, biased, deceptive or
presumptive. IA/RAs are also cautioned against including statements with
complex terms and excessive details designed to exploit inexperienced investors
or statements which are inconsistent with the nature and risk and return
profile of a product.
Additionally,
the Code also sets out specific prohibitions against certain practices, such as
the use of references to
any report, as free, unless it is actually free, assured returns, use of
superlative terms, and more importantly, statements which ascribe qualitative
advantages over other intermediaries and references to past performance.
On a cursory glance, it is clear that the Code and the
Brand Use Guidelines will impact the existing marketing and advertising
strategies adopted by IAs to solicit and retain clients. Let’s first analyse
the upside. Firstly, there is hardly any room to critize the inclusion
of mandatory details and standard warnings in advertisements. These help
investors distinguish between legitimate and unregistered IAs, and separate the
grain from the chaff, so to speak. Secondly, the principle-based approach
adopted in respect of the general prohibitions will allow SEBI greater
flexibility in identifying and initiating action against certain IAs who adopt
unscrupulous and manipulative techniques to lure investors.
However, certain provisions of the
Code may impede an IA’s marketing activities without necessarily meeting the intended
purpose of investor protection. To start with, the scope of the term
‘advertisements’ is notably broad. It is unclear whether communications which
are not intended to solicit clients, such as generic branding activities, objective
commentary on market trends, educational content or tailored correspondence
with existing clients could constitute advertisements for the purpose of the
Code. To address the ambiguity, SEBI should issue a clarification on the kinds
of communication that will not fall within the purview of advertisements.
As seen above, the Code also imposes a
prohibition against including references to past performances in advertisements.
It must be noted that such inclusion was also discussed in the Concept Paper on
Regulation of Investment Advisers released in 2011 to deliberate on the
regulatory framework for IAs in India, wherein, ironically, it was proposed to
permit references to past, specific recommendations if accompanied by a list of
all recommendations made by the IA, within a preceding period of atleast a
year. However, the proposal did not find mention in the ensuing IA Regulations.
Further, considering the emphasis placed on performance data by investors while
selecting an IA, this could also limit an IA’s ability to demonstrate their
skills and provide investors with valuable information to enable them to
compare, determine and engage the best suited IA. In our view, the industry
should come together to validate the information, based on uniform external
benchmarks, to mitigate the underlying concern of IAs cherry-picking profitable
investment recommendations and presenting distorted records of past performance.
This information should then be put up in a centralised location, as is
currently being made available for customers using PMS and mutual fund products.
Similarly, the per se
prohibition against using statements ascribing ‘qualitative advantages’ over
other intermediaries is also restrictive and may present roadblocks in an IA’s efforts
to carve a distinct brand identity in a rapidly expanding market. In our view, qualifying
such statements with the disclosure of verifiable information to substantiate
the claims made can achieve the intended purpose, in place of a complete
prohibition. It is also noteworthy to emphasize that these prohibitions do very
little to address unregistered IA activities, which form the lion’s share of
malpractices plaguing the investment advisory space. In fact, SEBI should curb
the unregistered players with strong action, so that the regulated can draw
comfort that they are not paying a large compliance cost in vain.
In summary, it appears that viable
alternatives that might better address concerns associated with misleading
marketing practices could be tweaked or clarified allowing ‘good’ marketing
while prohibiting dubious types.
No comments:
Post a Comment